quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:45:43·78d
SECFiling
Maze Therapeutics Inc. logo

Maze Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

MAZE· Maze Therapeutics Inc.
Health Care
Original source

Companies

  • MAZE
    Maze Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 18UpdateTruist$68.00
  • Mar 10UpdateMizuho$97.00
  • Dec 4UpdateWells Fargo$55.00
  • Nov 14UpdateRaymond James-
  • Sep 2UpdateBTIG Research$30.00
  • Jul 23UpdateH.C. Wainwright$34.00

Related

  • SEC1d
    Maze Therapeutics Inc. filed SEC Form 8-K: Other Events
  • SEC1d
    SEC Form 424B5 filed by Maze Therapeutics Inc.
  • PR2d
    Maze Therapeutics Announces $150 Million Registered Offering
  • INSIDER21d
    SEC Form 4 filed by Bernstein Harold
  • INSIDER21d
    SEC Form 4 filed by Bachrodt Amy
  • INSIDER22d
    SEC Form 4 filed by Dandekar Atul
  • INSIDER23d
    SEC Form 4 filed by Kumar Neil
  • INSIDER23d
    SEC Form 3 filed by new insider Kumar Neil
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022